Laboratory Of Stock Analysis

LH Stock  USD 212.22  4.90  2.26%   
Laboratory of is undervalued with Real Value of 247.02 and Target Price of 270.51. The main objective of Laboratory stock analysis is to determine its intrinsic value, which is an estimate of what Laboratory of is worth, separate from its market price. There are two main types of Laboratory's stock analysis: fundamental analysis and technical analysis.
The Laboratory stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Laboratory's ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Laboratory Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The book value of Laboratory was now reported as 96.55. The company has Price/Earnings To Growth (PEG) ratio of 0.79. Laboratory recorded earning per share (EPS) of 8.84. The entity last dividend was issued on the 29th of May 2025. The firm had 1164:1000 split on the 3rd of July 2023. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina. Laboratory Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 75000 people. To find out more about Laboratory of contact Paul Kirchgraber at 336 229 1127 or learn more at https://www.labcorp.com.

Laboratory Quarterly Total Revenue

3.33 Billion

Laboratory Investment Alerts

Laboratory generated a negative expected return over the last 90 days
Laboratory has a strong financial position based on the latest SEC filings
Over 96.0% of the company shares are owned by institutional investors
On 12th of March 2025 Laboratory paid $ 0.72 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: Clinical Trial Services Research Report 2025 Oncology, Neurology, Dermatology, CVD, Laboratory, Monitoring, Recruitment, PV, Data Management - Global Forecast to 2030

Laboratory Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Laboratory previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
15th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Laboratory Largest EPS Surprises

Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1997-07-29
1997-06-300.060.05-0.0116 
1999-07-22
1999-06-300.130.150.0215 
1998-03-17
1997-12-31-0.12-0.10.0216 
View All Earnings Estimates

Laboratory Environmental, Social, and Governance (ESG) Scores

Laboratory's ESG score is a quantitative measure that evaluates Laboratory's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Laboratory's operations that may have significant financial implications and affect Laboratory's stock price as well as guide investors towards more socially responsible investments.

Laboratory Thematic Classifications

In addition to having Laboratory stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Laboratory Stock Institutional Investors

Shares
Dimensional Fund Advisors, Inc.2024-12-31
1.4 M
Jpmorgan Chase & Co2024-12-31
1.3 M
Veritas Investment Partners (uk) Ltd.2024-12-31
1.2 M
Amundi2024-12-31
1.1 M
Amvescap Plc.2024-12-31
1.1 M
Nordea Investment Mgmt Bank Demark A/s2024-12-31
1.1 M
Norges Bank2024-12-31
M
Alliancebernstein L.p.2024-12-31
M
Northern Trust Corp2024-12-31
M
Vanguard Group Inc2024-12-31
9.7 M
Blackrock Inc2024-12-31
9.3 M
Note, although Laboratory's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Laboratory Market Capitalization

The company currently falls under 'Large-Cap' category with a market capitalization of 18.17 B.

Laboratory Profitablity

The company has Net Profit Margin (PM) of 0.06 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.07 %, which signifies that for every $100 of sales, it has a net operating income of $0.07.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.09  0.14 
Return On Capital Employed 0.07  0.07 
Return On Assets 0.04  0.04 
Return On Equity 0.09  0.18 

Management Efficiency

Laboratory has Return on Asset (ROA) of 0.0405 % which means that for every $100 of assets, it generated a profit of $0.0405. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0936 %, which means that it produced $0.0936 on every 100 dollars invested by current stockholders. Laboratory's management efficiency ratios could be used to measure how well Laboratory manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Laboratory's Return On Tangible Assets are decreasing as compared to previous years. The Laboratory's current Return On Equity is estimated to increase to 0.18, while Return On Capital Employed is projected to decrease to 0.07. As of now, Laboratory's Other Current Assets are increasing as compared to previous years. The Laboratory's current Total Current Assets is estimated to increase to about 5 B, while Intangible Assets are projected to decrease to under 2.1 B.
Last ReportedProjected for Next Year
Book Value Per Share 96.49  101.31 
Tangible Book Value Per Share(21.44)(22.51)
Enterprise Value Over EBITDA 13.76  10.95 
Price Book Value Ratio 2.38  3.26 
Enterprise Value Multiple 13.76  10.95 
Price Fair Value 2.38  3.26 
Enterprise Value7.4 B7.8 B
Examining the leadership quality of Laboratory of offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield
0.0133
Operating Margin
0.0693
Profit Margin
0.0574
Forward Dividend Yield
0.0133
Beta
0.973

Technical Drivers

As of the 22nd of April, Laboratory secures the Mean Deviation of 1.16, standard deviation of 1.62, and Risk Adjusted Performance of (0.15). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratory, as well as the relationship between them.

Laboratory Price Movement Analysis

The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. Laboratory Triple Exponential Moving Average indicator shows smoothing effect of Laboratory price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Laboratory Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Laboratory insiders, such as employees or executives, is commonly permitted as long as it does not rely on Laboratory's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Laboratory insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Laboratory Outstanding Bonds

Laboratory issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Laboratory uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Laboratory Predictive Daily Indicators

Laboratory intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Laboratory stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Laboratory Corporate Filings

8K
10th of April 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
4th of April 2025
Other Reports
ViewVerify
F4
3rd of April 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
31st of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
7th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
4th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
27th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
26th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Laboratory Forecast Models

Laboratory's time-series forecasting models are one of many Laboratory's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Laboratory's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Laboratory Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Laboratory prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Laboratory shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Laboratory. By using and applying Laboratory Stock analysis, traders can create a robust methodology for identifying Laboratory entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.07  0.14 
Operating Profit Margin 0.09  0.17 
Net Profit Margin 0.06  0.07 
Gross Profit Margin 0.27  0.42 

Current Laboratory Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Laboratory analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Laboratory analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
270.51Strong Buy20Odds
Laboratory of current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Laboratory analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Laboratory stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Laboratory, talking to its executives and customers, or listening to Laboratory conference calls.
Laboratory Analyst Advice Details

Laboratory Stock Analysis Indicators

Laboratory of stock analysis indicators help investors evaluate how Laboratory stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Laboratory shares will generate the highest return on investment. By understating and applying Laboratory stock analysis, traders can identify Laboratory position entry and exit signals to maximize returns.
Begin Period Cash Flow536.8 M
Long Term Debt5.3 B
Common Stock Shares Outstanding84.2 M
Total Stockholder Equity8.1 B
Tax Provision212.4 M
Quarterly Earnings Growth Y O Y-0.052
Property Plant And Equipment NetB
Cash And Short Term Investments1.5 B
Cash1.5 B
Accounts Payable875.8 M
Net Debt5.8 B
50 Day M A239.0428
Total Current Liabilities3.3 B
Other Operating Expenses11.9 B
Non Current Assets Total13.6 B
Forward Price Earnings13.5685
Non Currrent Assets Other652.2 M
Stock Based Compensation116.7 M

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
FinTech Suite
Use AI to screen and filter profitable investment opportunities